Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 4 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 12097213

    Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy

    The Board of Regents of the University of Texas System · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  2. US 12098385

    Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  3. US 12090183

    Methods of treating solid or lymphatic tumors by combination therapy

    CG ONCOLOGY, INC. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  4. US 12090142

    Combination therapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  5. US 12091675

    Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression

    Takeda Pharmaceutical Company Limited · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  6. US 12090145

    Combination therapy for treating or preventing depression or other mood diseases

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  7. US 12083113

    Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients

    Northwestern University · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  8. US 12076409

    Polymer-drug conjugates for combination anticancer therapy

    The Regents of the University of California · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  9. US 12070500

    Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis

    VACCINEX, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  10. US 12064511

    Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy

    The Regents of the University of California · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  11. US 12042529

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  12. US 12036256

    Adoptive cellular therapy

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  13. US 12036405

    System and method of electric-induced acoustic tomography for electrotherapy monitoring

    The Board of Regents of the University of Oklahoma · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  14. US 12031157

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  15. US 12025615

    Methods of classifying response to immunotherapy for cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  16. US 12024718

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  17. US 11998568

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  18. US 12000829

    Selection of patients for combination therapy

    Syndax Pharmaceuticals, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  19. US 11986455

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  20. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  21. US 11980637

    Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy

    United Kingdom Research and Innovation · Granted May 14, 2024 · Expires May 9, 2044

    granted
  22. US 11976293

    Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies

    The Regents of the University of California · Granted May 7, 2024 · Expires May 2, 2044

    granted
  23. US 11969499

    Hydrogel delivery of sting immunotherapy for treatment cancer

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  24. US 11971410

    Methods of classifying response to immunotherapy for cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted